Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Matinas Biopharma Holdings, Inc. Common Stock (NY: MTNB )

0.5400 +0.0100 (+1.89%)
Streaming Delayed Price Updated: 1:56 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Matinas Biopharma Holdings, Inc. Common Stock

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Grab Holdings Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Looking Into Matinas BioPharma Hldgs's Recent Short Interest
Via Benzinga
Matinas BioPharma Hldgs's Earnings: A Preview
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Nasdaq Down 500 Points; Uber Shares Dip After Q3 Results
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Crude Oil Gains 1%; Meta Shares Fall Following Q3 Results
Via Benzinga
Exposures Fossil Fuels
Nasdaq Down Over 200 Points; Microsoft Shares Fall After Q1 Results
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
MTNB Stock Earnings: Matinas BioPharma Hldgs Meets EPS for Q2 2024
MTNB stock results show that Matinas BioPharma Hldgs met analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Penny Stock Sleepers: 7 Under-the-Radar Gems Ready to Launch
Penny stocks to buy understandably offers many enticing attributes, not least of which is the potential for tremendous returns. 
Via InvestorPlace
MTNB Stock Earnings: Matinas BioPharma Hldgs Meets EPS for Q1 2024
MTNB stock results show that Matinas BioPharma Hldgs met analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
MTNB Stock Earnings: Matinas BioPharma Hldgs Reported Results for Q4 2023
Matinas BioPharma Hldgs just reported results for the fourth quarter of 2023. 
Via InvestorPlace
Why Is Fungal Infections-Focused Matinas BioPharma Stock Trading Higher On Friday?
Progress with Matinas BioPharma's MAT2203 for invasive fusarium infection. Clinical response achieved in patients resistant to other antifungals. 
Via Benzinga
Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per... 
Via Benzinga
Why Is Inflammatory Focused Matinas BioPharma Stock Trading Higher Today?
Wednesday, Matinas BioPharma Holdings Inc (NASDAQ: MTNB) announced results from a series of in vivo studies demonstrating successful oral delivery of two lipid nanocrystal (LNC)-formulated small... 
Via Benzinga
What's Going On With Matinas Biopharma Holdings Stock?
Matinas Biopharma Holdings, Inc. (AMEX:MTNB) shares are trading higher on Wednesday after the company announced complete clinical resolution of a patient's recurrent hemorrhagic cystitis following... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Semler Scientific Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket
Gainers Amyris, Inc. (NASDAQ: AMRS) shares surged 45.4% to $0.0958 in pre-market trading. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy. 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.